Patents by Inventor Simon Bjerregaard Jensen

Simon Bjerregaard Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tablet formulation comprising a GLP-1 peptide and a delivery agent
    Patent number: 11033499
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: June 15, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL) AMINO) CAPRYLIC ACID
    Publication number: 20180360918
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: August 30, 2018
    Publication date: December 20, 2018
    Inventors: Per Sauerberg, Simon Bjerregaard Jensen, Flemming S. Nielsen
  • TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT
    Publication number: 20180235888
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Tablet formulation comprising semaglutide and a delivery agent
    Patent number: 9993430
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: June 12, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
    Patent number: 9387176
    Abstract: The present invention relates to a method for spray-drying of protein solutions and the spray-dried protein product. The invention also relates to pharmaceutical compositions containing such spray-dried protein, to methods of treating diabetes and hyperglycaemia using the spray-dried protein of the invention and to the use of such spray-dried protein in the treatment of diabetes and hyperglycaemia.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: July 12, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Svend Havelund, Simon Bjerregaard Jensen
  • TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT
    Publication number: 20150150811
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: June 19, 2013
    Publication date: June 4, 2015
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Stable Non-Aqueous Pharmaceutical Compositions
    Publication number: 20140349924
    Abstract: The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia.
    Type: Application
    Filed: July 21, 2014
    Publication date: November 27, 2014
    Inventors: Simon Bjerregaard Jensen, Svend Havelund, Florian A. Foeger
  • Stable formulation of modified GLP-1
    Patent number: 8846618
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: September 30, 2014
    Assignee: Novo Nordisk A/S
    Inventors: James M. Flink, Silke Møller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund
  • Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
    Publication number: 20110144010
    Abstract: The present invention relates to a solid or semi-solid pharmaceutical composition that includes a polypeptide drug, at least one polar organic solvent, at least one surfactant, at least one hydrophilic component and which composition is spontaneously dispersible.
    Type: Application
    Filed: May 30, 2008
    Publication date: June 16, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Florian Anders Föger, Per-Olof Wahlund, Tomas Landh, Simon Bjerregaard Jensen, Svend Havelund
  • STABLE FORMULATION OF MODIFIED GLP-1
    Publication number: 20100234299
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 16, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: JAMES M. FLINK, SILKE MØLLER LARSEN, SIMON BJERREGAARD JENSEN, DORTHE KOT ENGELUND
  • Stable Non-Aqueous Pharmaceutical Compositions
    Publication number: 20100190706
    Abstract: The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising insulinotropic peptide and semi-polar protic organic solvent.
    Type: Application
    Filed: May 30, 2008
    Publication date: July 29, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: Simon Bjerregaard Jensen, Svend Havelund, Anders Föger, Bernd W. Müller
  • Stable Non-Aqueous Pharmaceutical Compositions
    Publication number: 20100144592
    Abstract: The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising dehydrated active polypeptide comprising 10-100 amino acids and at least one semi-polar protic organic solvent.
    Type: Application
    Filed: May 30, 2008
    Publication date: June 10, 2010
    Applicant: Nove Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Svend Havelund, Florian Anders Föger
  • HIGHLY CONCENTRATED INSULIN SOLUTIONS AND COMPOSITIONS
    Publication number: 20100120660
    Abstract: Highly concentrated insulin solutions and pharmaceutical compositions are described as are methods of their preparation and uses thereof.
    Type: Application
    Filed: April 30, 2008
    Publication date: May 13, 2010
    Inventors: Per Balschmidt, Per-Olof Wahlund, Svend Havelund, Simon Bjerregaard Jensen
  • Stable Formulation of Modified GLP-1
    Publication number: 20090111752
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: December 24, 2008
    Publication date: April 30, 2009
    Applicant: Novo Nordisk A/S
    Inventors: James M. Flink, Silke Moller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund
  • Stable formulation of modified GLP-1
    Publication number: 20080167226
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: April 11, 2007
    Publication date: July 10, 2008
    Applicant: Novo Nordisk A/S
    Inventors: James M. Flink, Silke Moller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund
  • Stable formulation of modified GLP-1
    Publication number: 20030119734
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: June 27, 2002
    Publication date: June 26, 2003
    Inventors: James M. Flink, Silke Moller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund